Science & Technology

VacciRAPTOR: High-throughput, Continuous Flow-Through System for Psoralen-UVA Inactivation

Department of Defense — Defense Health Agency

Opportunity #: HT9425-25-C-0028

Award Ceiling

$1.3M

Award Floor

$1.3M

Close Date

Nov 1, 2027

596 days left

Total Funding

$1.3M

Expected Awards

Posted Date

Jul 2, 2025

Cost Sharing Required

Grants.gov ID

sbir-HT9425-25-C-0028

Description

SBIR Phase Phase II award: "VacciRAPTOR: High-throughput, Continuous Flow-Through System for Psoralen-UVA Inactivation" awarded to SOLARIS VACCINES, INC. in FORT COLLINS, Colorado. Funded by Department of Defense (Defense Health Agency). Award amount: $1,298,431.22. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.

Eligible Applicants

Small businesses

Apply on Grants.gov

Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.

View on Grants.gov

Disclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.